Takikawa H - Search Results

1

Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.

Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, Takahashi S, Bianchi I, Zermiani P, Podda M, Ohira H, Invernizzi P, Takikawa H. Tanaka A, et al. Among authors: takikawa h. J Hepatol. 2009 Jun;50(6):1202-9. doi: 10.1016/j.jhep.2009.01.015. Epub 2009 Mar 5. J Hepatol. 2009. PMID: 19376604

2

Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats.

Takikawa H, Sano N, Yamazaki R, Yamanaka M. Takikawa H, et al. J Hepatol. 1995 Jan;22(1):88-93. doi: 10.1016/0168-8278(95)80265-7. J Hepatol. 1995. PMID: 7751593

3

Effects of organic anions and bile acids on biliary lipid excretion in hyperbilirubinemic mutant Sprague-Dawley rats.

Takikawa H, Sano N, Wako Y, Yamanaka M. Takikawa H, et al. J Hepatol. 1993 Feb;17(2):247-52. doi: 10.1016/s0168-8278(05)80046-7. J Hepatol. 1993. PMID: 8445239

4

Effect of organic anions and bile acid conjugates on biliary excretion of taurine-conjugated bile acid sulfates in the rat.

Uegaki S, Takikawa H, Yamanaka M. Uegaki S, et al. Among authors: takikawa h. Steroids. 1999 Nov;64(11):790-5. doi: 10.1016/s0039-128x(99)00071-9. Steroids. 1999. PMID: 10577837

5

Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats.

Hojo M, Sano N, Takikawa H. Hojo M, et al. Among authors: takikawa h. J Gastroenterol Hepatol. 2003 Jul;18(7):815-21. doi: 10.1046/j.1440-1746.2003.03053.x. J Gastroenterol Hepatol. 2003. PMID: 12795754

6

Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting.

Takikawa H, Takamori Y, Kumagi T, Onji M, Watanabe M, Shibuya A, Hisamochi A, Kumashiro R, Ito T, Mitsumoto Y, Nakamura A, Sakaguchi T. Takikawa H, et al. Hepatol Res. 2003 Nov;27(3):192-195. doi: 10.1016/s1386-6346(03)00232-8. Hepatol Res. 2003. PMID: 14585395

7

Biliary excretion of azelnidipine, a calcium antagonist, in rats.

Hanawa N, Sano N, Takikawa H. Hanawa N, et al. Among authors: takikawa h. J Gastroenterol Hepatol. 2004 Apr;19(4):413-7. doi: 10.1111/j.1440-1746.2003.03315.x. J Gastroenterol Hepatol. 2004. PMID: 15012778

8

Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients.

Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Takikawa H, et al. Hepatol Res. 2004 Jul;29(3):153-159. doi: 10.1016/j.hepres.2004.03.006. Hepatol Res. 2004. PMID: 15203079

9

Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats.

Tachizawa H, Sano N, Takikawa H. Tachizawa H, et al. Among authors: takikawa h. J Gastroenterol Hepatol. 2004 Sep;19(9):1016-22. doi: 10.1111/j.1440-1746.2004.03411.x. J Gastroenterol Hepatol. 2004. PMID: 15304119

10

Biliary excretion of olmesartan, an anigotensin II receptor antagonist, in the rat.

Takayanagi M, Sano N, Takikawa H. Takayanagi M, et al. Among authors: takikawa h. J Gastroenterol Hepatol. 2005 May;20(5):784-8. doi: 10.1111/j.1440-1746.2005.03792.x. J Gastroenterol Hepatol. 2005. PMID: 15853995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters